Frontline Treatment of COPD
Management of Stable COPD
Conclusion
The earlier the diagnosis of COPD, the longer the preservation
of lung function. This underscores the need for office spirometry
to make an early diagnosis. The primary care physician can, through
careful interest and perseverance, help patients with more advanced
COPD deal with their chronic disability. An emphasis on smoking
cessation, compliance with medication programs, exercise, and oxygen
therapy when necessary will in most cases improve–and often
stabilize–pul-monary function. Most often, patients will “plateau”
and will experience long periods between “relapses”
or exacerbations. These plateaus are very gratifying to patients,
their families, and the physician and clinic staff.
When interviewing patients, look for certain symptoms (such as
increased dyspnea, cough, fever, edema, or fatigue) that might suggest
a nonspecific exacerbation of their COPD. The practitioner becomes
very sensitive to changes in a patient's condition. Increased depression,
fatigue, a change in sleep habits, decreased appetite, or other
unexplained symptoms may in fact be the clinical manifestations
of a deterioration in pulmonary function. A brief physical examination
focusing on the work required by breathing and the appearance of
the patient, brief spirometric recordings and oximetry readings,
or a change on the patient’s chest x-ray frequently give clues
about the patient's clinical deterioration. These same details can
suggest changes in the patient’s medication program that might
prevent hospitalization and further deterioration in pulmonary function.
References
Bone RC. A step-care approach to managing COPD. J Respir Dis 1991;12:727-740.
A practical guide to the pharmacologic management of COPD.
Casaburi R, Petty TL (eds). Principles and Practice of Pulmonary
Rehabilitation. Chicago: WB Saunders, 1993; 508 pages. A full-length
textbook on pulmonary rehabilitation for COPD and related disorders
such as asthma, cystic fibrosis, and interstitial lung disease.
Dorinsky PM, Reisner C, Ferguson GT, et al. The combination of
ipratropium and albuterol optimizes pulmonary function reversibility
testing in patients with COPD. Chest 1999;115:966-971. A greater
increase in fev1 was found in 1,067 stable COPD patients, 30 minutes
after inhaling the combination. This response exceeded the fev responses
from the individual drugs.
Ferguson GT, Cherniack RM. Management of chronic obstructive pulmonary
disease. N Engl J Med 1993;328:1017-1022. A thorough review of all
the treatment medications that are useful in the management of COPD.
Ikeda A, Nishimura K, Koyama H, Izumi T. Bronchodilating effects
of combined therapy with clinical dosages of ipratropium bromide
and salbutamol for stable COPD: Comparison with ipratropium alone.
Chest 1995;107:401-405. Salmeterol is the name for albuterol outside
of the U.S.A. This report showed an additive effect from salbutamol
(albuterol) added to ipratropium.
Petty TL (Chairman). Combivent Inhalation Aerosol Study Group.
In chronic obstructive pulmonary disease, a combination of ipratropium
and albuterol is more effective than either agent alone. An 85-day
multicenter trial. Chest 1994;105:1411-1419. The initial report
on the increased peak effect and longer duration of the combination
product compared with each component.
Petty TL (Chairman). Nocturnal Oxygen Therapy Trial Group, (nott).
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive
lung disease. A clinical trial. Ann Intern Med 1980;93:391-398.
This multicenter trial demonstrated improved survival with continuous
oxygen therapy provided by an ambulatory system compared with nocturnal
oxygen delivered from a stationary system.
Petty TL, Bliss PL. Ambulatory oxygen therapy, exercise, and survival
with advanced COPD. Respir Care 2000;45:204-211. This retrospective
analysis of survival and hospitalizations revealed that ability
to increase exercise and receiving ambulatory oxygen resulted in
better outcomes compared with patients who had less ability to exercise
and who received oxygen from a stationary source.
|